Event
Singapore Life Sciences Roundtable
Wednesday, September 3, 2025
This intimate, industry-focused session will bring together legal and compliance professionals from multinational pharmaceutical, medtech, and biotech companies to explore how recent global developments are reshaping the regulatory and transactional landscape across Asia-Pacific.
Topics include:
- The New DOJ White Collar Enforcement Playbook
What it means for APAC operations and compliance functions - The New U.S. Administration and the FDA
Taking stock of paradigm-shifting developments in drug and device regulation - Life Sciences Transactions in APAC
Navigating deal risks, regulatory scrutiny, and cross-border trends
PROGRAM
Registration and Refreshments: 9:30 a.m. – 10:00 a.m. SGT
Sidley Presentation and Roundtable Dialogue: 10:00 a.m. – 12:00 p.m. SGT
Networking Lunch: 12:00 p.m. – 1:00 p.m. SGT
For questions or more information, please contact asiaevents@sidley.com.
連絡先
Offices
得意分野
Suggested News & Insights
A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Is my product a medical device? EU Court judgment clarifies that the test includes objective function and intended purpose, and provides guidance relevant to software and AI-enabled toolsAugust 31, 2026UK Looks To Modernize Medicines And Medical Device Regulation In The Era Of AIAugust 26, 2026Swiss MedTech 2026Tuesday, August 25, 2026CMS’ CY 2027 OPPS and PFS Proposed Rules Include Major Changes to Reimbursement for 340B Hospitals, Data Reporting, and Digital HealthAugust 24, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

